| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.23 | 0.2 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.07 | 0.2 |